首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1457998

全球流動止血劑市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Flowable Hemostats Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 235 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球可流動止血劑市場的市場規模將從 2023 年的 7.6278 億美元達到近 12.9417 億美元，2024-2032 年研究期間CAGR為 6.05%。

可流動止血劑是設計用於控制手術或外傷期間出血的醫療物質。這些藥物通常是液體或凝膠，可以輕鬆應用於出血部位。這些止血劑可促進血液凝固並促進傷口更快癒合，使其成為醫療環境中有效控制出血的寶貴工具。

市場動態

由於全球外科手術數量的增加和出血性疾病盛行率的上升，可流動止血劑市場經歷了強勁成長。這些止血劑在微創手術中的關鍵作用提高了它們的受歡迎程度，有助於市場擴張。醫療技術和外科實踐的進步做出了巨大貢獻，創造了對有效止血解決方案的需求。然而，產品核准的嚴格監管要求帶來了挑戰，對這些解決方案的成本效益的擔憂可能會阻礙可流動止血劑的市場成長。儘管存在這些障礙，在持續的研發努力的推動下，可流動止血劑市場仍在不斷發展，以解決這些限制並滿足對高效止血解決方案不斷成長的需求。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球流動止血劑市場的各個細分市場進行了包容性評估。可流動止血劑產業的成長和趨勢為本研究提供了整體方法。

市場區隔

可流動止血劑市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按材質

豬明膠
牛明膠

按申請

一般外科
心臟外科
血管外科
神經與脊椎外科
骨科手術
其他

按最終用戶

醫院
門診手術中心
診所

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的可流動止血器市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

按地區分類的全球流動止血劑市場佔有率（代表性圖）
全球流動止血劑市場佔有率

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。可流動止血劑市場的主要參與者包括強生公司、百特國際公司、泰利福公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：流動止血劑公司的競爭格局

可流動止血劑市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Johnson & Johnson

公司簡介
公司收入
產品
最近的發展

Baxter International Inc.

公司簡介
公司收入
產品
最近的發展

Teleflex Incorporated

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113935

The global demand for Flowable Hemostats Market is presumed to reach the market size of nearly USD 1294.17 Million by 2032 from USD 762.78 Million in 2023 with a CAGR of 6.05% under the study period 2024 - 2032.

Flowable hemostats are medical substances designed to control bleeding during surgeries or traumatic injuries. These agents are typically liquid or gel, allowing for easy application to bleeding sites. These hemostats promote blood clotting and facilitate faster wound healing, making them valuable tools in medical settings to manage hemorrhage effectively.

MARKET DYNAMICS

The flowable hemostats market experiences robust growth driven by the increasing number of surgical procedures globally and the rising prevalence of bleeding disorders. These hemostats' critical role in minimally invasive surgeries enhances their popularity, contributing to market expansion. Medical technology and surgical practice advancements contribute significantly, creating a demand for effective hemostatic solutions. However, stringent regulatory requirements for product approval pose challenges, and concerns regarding the cost-effectiveness of these solutions may impede flowable hemostats' market growth. Despite these hurdles, the flowable hemostats market continues to evolve, driven by ongoing research & development efforts to address these restraints and meet the growing demand for efficient hemostatic solutions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of flowable hemostats. The growth and trends of flowable hemostats industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the flowable hemostats market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Material

Porcine Gelatin
Bovine Gelatin

By Application

General Surgery
Cardiac Surgery
Vascular Surgery
Neuro & Spine Surgery
Orthopedic Surgery
Others

By End-User

Hospitals
Ambulatory Surgery Centers
Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Flowable Hemostats market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL FLOWABLE HEMOSTATS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global Flowable Hemostats Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Flowable Hemostats market include Johnson & Johnson, Baxter International, Inc., Teleflex Incorporated. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . FLOWABLE HEMOSTATS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Material
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY MATERIAL

5.1 Overview by Material
5.2 Historical and Forecast Data
5.3 Analysis by Material
5.4 Porcine Gelatin Historic and Forecast Sales by Regions
5.5 Bovine Gelatin Historic and Forecast Sales by Regions

6 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 General Surgery Historic and Forecast Sales by Regions
6.5 Cardiac Surgery Historic and Forecast Sales by Regions
6.6 Vascular Surgery Historic and Forecast Sales by Regions
6.7 Neuro & Spine Surgery Historic and Forecast Sales by Regions
6.8 Orthopedic Surgery Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY END-USER

7.1 Overview by End-User
7.2 Historical and Forecast Data
7.3 Analysis by End-User
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
7.6 Clinics Historic and Forecast Sales by Regions

8 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE FLOWABLE HEMOSTATS COMPANIES

9.1. Flowable Hemostats Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF FLOWABLE HEMOSTATS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Johnson & Johnson
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Baxter International Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Teleflex Incorporated
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments